Contact this trialFirst, we need to learn more about you.
Orexin Antagonist
Suvorexant for Post-Traumatic Stress Disorder
Recruiting2 awardsPhase 4
San Francisco, California
"This trial aims to investigate whether a medication called suvorexant, which targets a specific brain chemical called orexin, can help Veterans with PTSD and insomnia by enhancing fear extinction. Fear extinction is a
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service